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INTRODUCTION
Capillary leak syndrome  (CLS) is a rare clinical disease that 
causes edema, hypoproteinemia, episodic hypotension, 
dyspnea, hyponatremia, and weight gain that can be life 
threatening1. Although the underlying pathology is 
currently unknown, CLS is thought to be secondary to a 
systemic process associated with hyperpermeability of the 
body's microcirculation, resulting from a diffuse and 
severe disruption of the endothelium and causing 
generalized edema and often acute respiratory distress2.
CASE PRESENTATION
A 60 year old female with metastatic pancreatic cancer 
undergoing gemcitabine treatment presented with weight 
gain, dyspnea on exertion, and orthopnea.  Since the 
initiation of gemcitabine three months prior to presentation, 
the patient had noticed progressive weight gain - 5 lbs a 
week, with the rate of weight gain accelerating recently. 
This coincided with bilateral lower extremity swelling and 
abdominal distension.  On physical examination, the 
patient had jugular venous distension and lower extremity 
edema. Labs were significant for an albumin of 3.1 g/dL 
with a normal hepatic panel, a sodium of 131 mmol/L, and 
urine studies that were not consistent with nephrotic 
range proteinuria. Imaging had nonspecific findings. Chest 
X Ray demonstrated small bilateral pleural effusions and 
an abdominal ultrasound revealed mild ascites. Ventricular 
dysfunction and venous thromboses were excluded with 
an echocardiogram and lower extremity ultrasound. 
Ultimately, the anasarca was attributed to capillary leak 
syndrome induced by gemcitabine therapy.  
DIFFERENTIAL DIAGNOSIS 
Prior to presuming capillary leak syndrome, it was 
necessary to eliminate other causes of anasarca. 
Echocardiogram was done to rule out cardiac dysfunction. 
Urine studies indicated that a renal process causing 
nephrotic syndrome was not the predominant disease 
pathology. Abdominal ultrasound ruled out liver pathology.
OUTCOME AND FOLLOWUP
The patient was given diuretics and responded well over 
the course of a few days. Her hyponatremia resolved and 
she was sent home with an oral diuretic regimen. She was 
asked to monitor daily weights with instructions to report 
any changes of greater than 5 lbs to her doctor. Although 
she continued to be anasarcic, her dyspnea improved. 
Chemotherapy was discontinued, and the patient was 
readmitted to the hospital within two months due to 
progression of her pancreatic cancer. She was ultimately 
discharged home with hospice care.
DISCUSSION
Capillary leak syndrome (CLS) is a very rare (<1%) but 
important and severe adverse effect of gemcitabine 
therapy.  There are some emerging case reports of 
capillary leak syndrome secondary to treatments from 
taxanes such as docetaxel and paclitaxel. As demonstrated 
by this case, capillary leak syndrome is difficult to treat 
with diuretics alone. Other reports recommend that there 
may be a therapeutic effect from high dose corticosteroids 
when given in conjunction with diuretics. Corticosteroid 
prophylaxis given concurrently with gemcitabine therapy 
may decrease toxicity that can curtail potentially fatal 
outcomes.4 It will be important to determine if there is a 
dose dependent relationship between gemcitabine and 
CLS to ensure a safe medication profile. 
Moreover, falling albumin levels along with weight gain in 
patients receiving gemcitabine may be precursors to CLS, 
and such patients should be screened for potential 
respiratory symptoms. It is important to include capillary 
leak syndrome in the differential in patients presenting 
with anasarca not due to cardiac, renal, or hepatic causes 
as it may lead to earlier cessation of gemcitabine treatment 
and potentially improved outcomes. 
KEY POINTS
Our patient on gemcitabine therapy presented with 
anasarca, which was unexplained by specific organ failure, 
and likely was the result of gemcitabine induced capillary 
leak syndrome. Capillary leak syndrome is an uncommon 
and poorly understood adverse effect of gemcitabine.  More 
research is required to understand how to effectively treat or 
prevent this severe and potentially life threatening condition. 
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